Scientia Ventures
Venture Capital And Private Equity Principals
One Liberty Plaza
6 employees
- Employees
- 6
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Scientia Ventures Overview
- Headquarters
- One Liberty Plaza
- Website
- scientiavc.com
- Industry
- Venture Capital And Private Equity Principals
- Employees
- 6
- Company Email
- Available in AeroLeads
- NAICS
-
Miscellaneous Intermediation
Keywords
About Scientia Ventures
Scientia Ventures™ invests in early to mid-stage technology companies that target computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. Our strength is working with entrepreneurs and big ideas to build companies with the potential to transform healthcare. Our Partners have a long history of working together, many of whom are former founders, operators or CEO’s of important healthcare companies and who have domain expertise across healthcare, finance and intellectual property.
Scientia Ventures Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
- Phone contacts
- 1
- 33.3% coverage
Scientia Ventures Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| John Dessouki | Chief Financial Officer at Metabolics Pharma |
View
|
|
| Jonathan Finn, Cfa | Managing Member at Scientia Ventures | Virginia Beach, Virginia, United States |
View
|
| Harry Glorikian | Ai-driven Health Investor & Board Director | Greater Boston, United States |
Email
Phone
|
Employees by Management Level
Executive
1 profile
Director
1 profile
Individual contributor
1 profile
Compare Similar Companies to Scientia Ventures
Flagship Pioneering
Biotechnology Research
Holocene Advisors, LP
Investment Management
Syntax Data
Financial Services
Oberland Capital
Investment Management
VERIGRAFT
Biotechnology
Consilience AI
Software Development
Quincey Law
Law Practice
The Harry Glorikian Show
Venture Capital And Private Equity Principals
Metabolic Pharmaceuticals Pty. Ltd.
Biotechnology